mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |